<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Sat, 26 Jul 2008 07:43:51 BST</pubDate>


	<title>CiteULike: neils's Wilson</title>
	<description>CiteULike: neils's Wilson</description>


	<link>http://www.citeulike.org/user/neils/author/Wilson</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/neils/article/2773795"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/neils/article/2319613"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/neils/article/2207154"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/neils/article/2773795">
    <title>The minimum information about a genome sequence (MIGS) specification</title>
    <link>http://www.citeulike.org/user/neils/article/2773795</link>
    <description>&lt;i&gt;Nat Biotech, Vol. 26, No. 5. (May 2008), pp. 541-547.&lt;/i&gt;</description>
    <dc:title>The minimum information about a genome sequence (MIGS) specification</dc:title>

    <dc:creator>Dawn Field</dc:creator>
    <dc:creator>George Garrity</dc:creator>
    <dc:creator>Tanya Gray</dc:creator>
    <dc:creator>Norman Morrison</dc:creator>
    <dc:creator>Jeremy Selengut</dc:creator>
    <dc:creator>Peter Sterk</dc:creator>
    <dc:creator>Tatiana Tatusova</dc:creator>
    <dc:creator>Nicholas Thomson</dc:creator>
    <dc:creator>Michael Allen</dc:creator>
    <dc:creator>Samuel Angiuoli</dc:creator>
    <dc:creator>Michael Ashburner</dc:creator>
    <dc:creator>Nelson Axelrod</dc:creator>
    <dc:creator>Sandra Baldauf</dc:creator>
    <dc:creator>Stuart Ballard</dc:creator>
    <dc:creator>Jeffrey Boore</dc:creator>
    <dc:creator>Guy Cochrane</dc:creator>
    <dc:creator>James Cole</dc:creator>
    <dc:creator>Peter Dawyndt</dc:creator>
    <dc:creator>Paul De Vos</dc:creator>
    <dc:creator>Claude Depamphilis</dc:creator>
    <dc:creator>Robert Edwards</dc:creator>
    <dc:creator>Nadeem Faruque</dc:creator>
    <dc:creator>Robert Feldman</dc:creator>
    <dc:creator>Jack Gilbert</dc:creator>
    <dc:creator>Paul Gilna</dc:creator>
    <dc:creator>Frank Glockner</dc:creator>
    <dc:creator>Philip Goldstein</dc:creator>
    <dc:creator>Robert Guralnick</dc:creator>
    <dc:creator>Dan Haft</dc:creator>
    <dc:creator>David Hancock</dc:creator>
    <dc:creator>Henning Hermjakob</dc:creator>
    <dc:creator>Christiane Hertz-Fowler</dc:creator>
    <dc:creator>Phil Hugenholtz</dc:creator>
    <dc:creator>Ian Joint</dc:creator>
    <dc:creator>Leonid Kagan</dc:creator>
    <dc:creator>Matthew Kane</dc:creator>
    <dc:creator>Jessie Kennedy</dc:creator>
    <dc:creator>George Kowalchuk</dc:creator>
    <dc:creator>Renzo Kottmann</dc:creator>
    <dc:creator>Eugene Kolker</dc:creator>
    <dc:creator>Saul Kravitz</dc:creator>
    <dc:creator>Nikos Kyrpides</dc:creator>
    <dc:creator>Jim Leebens-Mack</dc:creator>
    <dc:creator>Suzanna Lewis</dc:creator>
    <dc:creator>Kelvin Li</dc:creator>
    <dc:creator>Allyson Lister</dc:creator>
    <dc:creator>Phillip Lord</dc:creator>
    <dc:creator>Natalia Maltsev</dc:creator>
    <dc:creator>Victor Markowitz</dc:creator>
    <dc:creator>Jennifer Martiny</dc:creator>
    <dc:creator>Barbara Methe</dc:creator>
    <dc:creator>Ilene Mizrachi</dc:creator>
    <dc:creator>Richard Moxon</dc:creator>
    <dc:creator>Karen Nelson</dc:creator>
    <dc:creator>Julian Parkhill</dc:creator>
    <dc:creator>Lita Proctor</dc:creator>
    <dc:creator>Owen White</dc:creator>
    <dc:creator>Susanna-Assunta Sansone</dc:creator>
    <dc:creator>Andrew Spiers</dc:creator>
    <dc:creator>Robert Stevens</dc:creator>
    <dc:creator>Paul Swift</dc:creator>
    <dc:creator>Chris Taylor</dc:creator>
    <dc:creator>Yoshio Tateno</dc:creator>
    <dc:creator>Adrian Tett</dc:creator>
    <dc:creator>Sarah Turner</dc:creator>
    <dc:creator>David Ussery</dc:creator>
    <dc:creator>Bob Vaughan</dc:creator>
    <dc:creator>Naomi Ward</dc:creator>
    <dc:creator>Trish Whetzel</dc:creator>
    <dc:creator>Ingio San Gil</dc:creator>
    <dc:creator>Gareth Wilson</dc:creator>
    <dc:creator>Anil Wipat</dc:creator>
    <dc:identifier>doi:10.1038/nbt1360</dc:identifier>
    <dc:source>Nat Biotech, Vol. 26, No. 5. (May 2008), pp. 541-547.</dc:source>
    <dc:date>2008-05-08T23:35:18-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>Nat Biotech</prism:publicationName>
    <prism:volume>26</prism:volume>
    <prism:number>5</prism:number>
    <prism:startingPage>541</prism:startingPage>
    <prism:endingPage>547</prism:endingPage>
    <prism:publisher>Nature Publishing Group</prism:publisher>
    <prism:category>bioinformatics</prism:category>
    <prism:category>genomics</prism:category>
    <prism:category>information</prism:category>
    <prism:category>sequencing</prism:category>
    <prism:category>standards</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/neils/article/2319613">
    <title>Protein production and purification.</title>
    <link>http://www.citeulike.org/user/neils/article/2319613</link>
    <description>&lt;i&gt;Nat Methods, Vol. 5, No. 2. (February 2008), pp. 135-146.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;In selecting a method to produce a recombinant protein, a researcher is faced with a bewildering array of choices as to where to start. To facilitate decision-making, we describe a consensus 'what to try first' strategy based on our collective analysis of the expression and purification of over 10,000 different proteins. This review presents methods that could be applied at the outset of any project, a prioritized list of alternate strategies and a list of pitfalls that trip many new investigators.</description>
    <dc:title>Protein production and purification.</dc:title>

    <dc:creator>S Gräslund</dc:creator>
    <dc:creator>P Nordlund</dc:creator>
    <dc:creator>J Weigelt</dc:creator>
    <dc:creator>J Bray</dc:creator>
    <dc:creator>O Gileadi</dc:creator>
    <dc:creator>S Knapp</dc:creator>
    <dc:creator>U Oppermann</dc:creator>
    <dc:creator>C Arrowsmith</dc:creator>
    <dc:creator>R Hui</dc:creator>
    <dc:creator>J Ming</dc:creator>
    <dc:creator>S Dhe-Paganon</dc:creator>
    <dc:creator>HW Park</dc:creator>
    <dc:creator>A Savchenko</dc:creator>
    <dc:creator>A Yee</dc:creator>
    <dc:creator>A Edwards</dc:creator>
    <dc:creator>R Vincentelli</dc:creator>
    <dc:creator>C Cambillau</dc:creator>
    <dc:creator>R Kim</dc:creator>
    <dc:creator>SH Kim</dc:creator>
    <dc:creator>Z Rao</dc:creator>
    <dc:creator>Y Shi</dc:creator>
    <dc:creator>TC Terwilliger</dc:creator>
    <dc:creator>CY Kim</dc:creator>
    <dc:creator>LW Hung</dc:creator>
    <dc:creator>GS Waldo</dc:creator>
    <dc:creator>Y Peleg</dc:creator>
    <dc:creator>S Albeck</dc:creator>
    <dc:creator>T Unger</dc:creator>
    <dc:creator>O Dym</dc:creator>
    <dc:creator>J Prilusky</dc:creator>
    <dc:creator>JL Sussman</dc:creator>
    <dc:creator>RC Stevens</dc:creator>
    <dc:creator>SA Lesley</dc:creator>
    <dc:creator>IA Wilson</dc:creator>
    <dc:creator>A Joachimiak</dc:creator>
    <dc:creator>F Collart</dc:creator>
    <dc:creator>I Dementieva</dc:creator>
    <dc:creator>MI Donnelly</dc:creator>
    <dc:creator>WH Eschenfeldt</dc:creator>
    <dc:creator>Y Kim</dc:creator>
    <dc:creator>L Stols</dc:creator>
    <dc:creator>R Wu</dc:creator>
    <dc:creator>M Zhou</dc:creator>
    <dc:creator>SK Burley</dc:creator>
    <dc:creator>JS Emtage</dc:creator>
    <dc:creator>JM Sauder</dc:creator>
    <dc:creator>D Thompson</dc:creator>
    <dc:creator>K Bain</dc:creator>
    <dc:creator>J Luz</dc:creator>
    <dc:creator>T Gheyi</dc:creator>
    <dc:creator>F Zhang</dc:creator>
    <dc:creator>S Atwell</dc:creator>
    <dc:creator>SC Almo</dc:creator>
    <dc:creator>JB Bonanno</dc:creator>
    <dc:creator>A Fiser</dc:creator>
    <dc:creator>S Swaminathan</dc:creator>
    <dc:creator>FW Studier</dc:creator>
    <dc:creator>MR Chance</dc:creator>
    <dc:creator>A Sali</dc:creator>
    <dc:creator>TB Acton</dc:creator>
    <dc:creator>R Xiao</dc:creator>
    <dc:creator>L Zhao</dc:creator>
    <dc:creator>LC Ma</dc:creator>
    <dc:creator>JF Hunt</dc:creator>
    <dc:creator>L Tong</dc:creator>
    <dc:creator>K Cunningham</dc:creator>
    <dc:creator>M Inouye</dc:creator>
    <dc:creator>S Anderson</dc:creator>
    <dc:creator>H Janjua</dc:creator>
    <dc:creator>R Shastry</dc:creator>
    <dc:creator>CK Ho</dc:creator>
    <dc:creator>D Wang</dc:creator>
    <dc:creator>H Wang</dc:creator>
    <dc:creator>M Jiang</dc:creator>
    <dc:creator>GT Montelione</dc:creator>
    <dc:creator>DI Stuart</dc:creator>
    <dc:creator>RJ Owens</dc:creator>
    <dc:creator>S Daenke</dc:creator>
    <dc:creator>A Schütz</dc:creator>
    <dc:creator>U Heinemann</dc:creator>
    <dc:creator>S Yokoyama</dc:creator>
    <dc:creator>K Büssow</dc:creator>
    <dc:creator>KC Gunsalus</dc:creator>
    <dc:identifier>doi:10.1038/nmeth.f.202</dc:identifier>
    <dc:source>Nat Methods, Vol. 5, No. 2. (February 2008), pp. 135-146.</dc:source>
    <dc:date>2008-02-01T14:36:35-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>Nat Methods</prism:publicationName>
    <prism:issn>1548-7105</prism:issn>
    <prism:volume>5</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>135</prism:startingPage>
    <prism:endingPage>146</prism:endingPage>
    <prism:category>expression</prism:category>
    <prism:category>genomics</prism:category>
    <prism:category>protein</prism:category>
    <prism:category>purification</prism:category>
    <prism:category>structural-genomics</prism:category>
    <prism:category>structure</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/neils/article/2207154">
    <title>Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.</title>
    <link>http://www.citeulike.org/user/neils/article/2207154</link>
    <description>&lt;i&gt;Mol Biol Cell, Vol. 6, No. 9. (September 1995), pp. 1145-1158.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;We have investigated the effects of wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase), on antigen-mediated signaling in the RBL-2H3 mast cell model. In RBL-2H3 cells, the cross-linking of high affinity IgE receptors (Fc epsilon R1) activates at least two cytoplasmic protein tyrosine kinases, Lyn and Syk, and stimulates secretion, membrane ruffling, spreading, pinocytosis, and the formation of actin plaques implicated in increased cell-substrate adhesion. In addition, Fc epsilon R1 cross-linking activates PI 3-kinase. It was previously shown that wortmannin causes a dose-dependent inhibition of PI 3-kinase activity and also inhibits antigen-stimulated degranulation. We report that the antigen-induced synthesis of inositol(1,4,5)P3 is also markedly inhibited by wortmannin. Consistent with evidence in other cell systems implicating phosphatidylinositol(3,4,5)P3 in ruffling, pretreatment of RBL-2H3 cells with wortmannin inhibits membrane ruffling and fluid pinocytosis in response to Fc epsilon R1 cross-linking. However, wortmannin does not inhibit antigen-induced actin polymerization, receptor internalization, or the actin-dependent processes of spreading and adhesion plaque formation that follow antigen stimulation in adherent cells. Wortmannin also fails to inhibit either of the Fc epsilon R1-coupled tyrosine kinases, Lyn or Syk, or the activation of mitogen-activated protein kinase as measured by in vitro kinase assays. Strikingly, there is substantial in vitro serine/threonine kinase activity in immunoprecipitates prepared from Fc epsilon R1-activated cells using antisera to the p85 subunit of PI 3-kinase. This activity is inhibited by pretreatment of the cells with wortmannin or by the direct addition of wortmannin to the kinase assay, suggesting that PI 3-kinase itself is capable of acting as a protein kinase. We conclude that Fc epsilon R1 cross-linking activates both lipid and protein kinase activities of PI 3-kinase and that inhibiting these activities with wortmannin results in the selective block of a subset of Fc epsilon R1-mediated signaling responses.</description>
    <dc:title>Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.</dc:title>

    <dc:creator>SA Barker</dc:creator>
    <dc:creator>KK Caldwell</dc:creator>
    <dc:creator>A Hall</dc:creator>
    <dc:creator>AM Martinez</dc:creator>
    <dc:creator>JR Pfeiffer</dc:creator>
    <dc:creator>JM Oliver</dc:creator>
    <dc:creator>BS Wilson</dc:creator>
    <dc:source>Mol Biol Cell, Vol. 6, No. 9. (September 1995), pp. 1145-1158.</dc:source>
    <dc:date>2008-01-08T09:53:43-00:00</dc:date>
    <prism:publicationYear>1995</prism:publicationYear>
    <prism:publicationName>Mol Biol Cell</prism:publicationName>
    <prism:issn>1059-1524</prism:issn>
    <prism:volume>6</prism:volume>
    <prism:number>9</prism:number>
    <prism:startingPage>1145</prism:startingPage>
    <prism:endingPage>1158</prism:endingPage>
    <prism:category>activity</prism:category>
    <prism:category>kinase</prism:category>
    <prism:category>lipid</prism:category>
    <prism:category>pi3k</prism:category>
    <prism:category>wortmannin</prism:category>
</item>



</rdf:RDF>

